Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. 1992

M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
Department of Biochemistry and Chemistry, Silesian Medical Academy, Medyków, Poland.

Plasma lipid peroxidation, activity of erythrocyte superoxide dismutase (SOD) and catalase, and serum antioxidant activity (AOA) in uremic patients were examined before and after hemodialysis. An increased level of lipid peroxidation, a decreased serum AOA level, and elevated SOD and normal catalase activity before hemodialysis were observed in uremic patients compared with controls. Hemodialysis was found to produce increased lipid peroxidation, a simultaneous decrease of SOD activity, and lack of any changes in serum AOA and erythrocyte catalase. It is suggested that intensification of lipid peroxidation during hemodialysis could account for accelerated progress of atherosclerosis in patients with renal insufficiency.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous

Related Publications

M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
January 1995, Romanian journal of internal medicine = Revue roumaine de medecine interne,
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
July 2015, Nephro-urology monthly,
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
January 1988, Terapevticheskii arkhiv,
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
August 2004, Pediatric nephrology (Berlin, Germany),
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
January 2003, Clinical hemorheology and microcirculation,
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
January 1992, Nephron,
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
April 2004, Lipids in health and disease,
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
February 1991, Zhonghua nei ke za zhi,
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
August 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Toborek, and T Wasik, and M Drózdz, and M Klin, and K Magner-Wróbel, and E Kopieczna-Grzebieniak
August 1995, Clinical chemistry,
Copied contents to your clipboard!